FI942691A - Menetelmä tuottaa/erittää proteiinia transformoidun homeen avulla käyttämällä Aspergilluksen endoksylanaasi II-geenistä saatuja ekspressioita/erittämistä sääteleviä alueita - Google Patents

Menetelmä tuottaa/erittää proteiinia transformoidun homeen avulla käyttämällä Aspergilluksen endoksylanaasi II-geenistä saatuja ekspressioita/erittämistä sääteleviä alueita Download PDF

Info

Publication number
FI942691A
FI942691A FI942691A FI942691A FI942691A FI 942691 A FI942691 A FI 942691A FI 942691 A FI942691 A FI 942691A FI 942691 A FI942691 A FI 942691A FI 942691 A FI942691 A FI 942691A
Authority
FI
Finland
Prior art keywords
endoxylanase
aspergillus
secretion
producing
regulatory regions
Prior art date
Application number
FI942691A
Other languages
English (en)
Swedish (sv)
Other versions
FI111958B (fi
FI942691A0 (fi
Inventor
Robertus Johannes Gouka
Den Hondel Cornelis Antoni Van
Wouter Musters
Hein Stam
Johannes Maria A Verbakel
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of FI942691A publication Critical patent/FI942691A/fi
Publication of FI942691A0 publication Critical patent/FI942691A0/fi
Application granted granted Critical
Publication of FI111958B publication Critical patent/FI111958B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477Hemicellulases not provided in a preceding group
    • C12N9/248Xylanases
    • C12N9/2482Endo-1,4-beta-xylanase (3.2.1.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008Endo-1,4-beta-xylanase (3.2.1.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031Beta-glucuronidase (3.2.1.31)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01032Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01136Glucuronoarabinoxylan endo-1,4-beta-xylanase (3.2.1.136), i.e. feraxanase or feraxan-endoxylanase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI942691A 1991-12-09 1994-06-08 Menetelmä tuottaa/erittää proteiinia transformoidun homeen avulla käyttämällä Aspergilluksen endoksylanaasi II-geenistä saatuja ekspressioita/erittämistä sääteleviä alueita FI111958B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL9102051 1991-12-09
NL9102051 1991-12-09
EP9202896 1992-12-09
PCT/EP1992/002896 WO1993012237A1 (en) 1991-12-09 1992-12-09 Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase ii gene

Publications (3)

Publication Number Publication Date
FI942691A true FI942691A (fi) 1994-06-08
FI942691A0 FI942691A0 (fi) 1994-06-08
FI111958B FI111958B (fi) 2003-10-15

Family

ID=19860011

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942691A FI111958B (fi) 1991-12-09 1994-06-08 Menetelmä tuottaa/erittää proteiinia transformoidun homeen avulla käyttämällä Aspergilluksen endoksylanaasi II-geenistä saatuja ekspressioita/erittämistä sääteleviä alueita

Country Status (12)

Country Link
US (1) US5705358A (fi)
EP (1) EP0672149B1 (fi)
JP (1) JP2866739B2 (fi)
AT (1) ATE204022T1 (fi)
AU (1) AU664223B2 (fi)
CA (1) CA2123416C (fi)
DE (1) DE69231995T2 (fi)
DK (1) DK0672149T3 (fi)
ES (1) ES2159519T3 (fi)
FI (1) FI111958B (fi)
WO (1) WO1993012237A1 (fi)
ZA (1) ZA929539B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
IL108175A0 (en) * 1992-12-24 1994-04-12 Gist Brocades Nv Cloning and expression of xylanase B
ATE412048T1 (de) * 1993-03-10 2008-11-15 Novozymes As Enzyme mit xylanaseaktivität aus aspergillus aculeatus
US5811381A (en) * 1996-10-10 1998-09-22 Mark A. Emalfarb Cellulase compositions and methods of use
US7883872B2 (en) * 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
DE69822142T2 (de) * 1997-04-07 2005-03-03 Unilever N.V. Transformation von schimmeln durch agrobacterium, insbesondere von der gattung aspergillus
EP0870835A1 (en) * 1997-04-07 1998-10-14 Unilever N.V. Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
US6015703A (en) * 1998-03-10 2000-01-18 Iogen Corporation Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
DE69922978T2 (de) * 1998-10-06 2005-12-08 Emalfarb, Mark Aaron, Jupiter Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
JP4834554B2 (ja) * 2003-11-06 2011-12-14 ジェネンコー・インターナショナル・インク 糸状菌におけるプロテアーゼ抑制剤及びその変異体の発現
ES2601327T3 (es) 2006-01-23 2017-02-14 Novozymes A/S Polipéptidos con actividad de lipasa y polinucleótidos que codifican los mismos
DK2059590T3 (en) 2006-07-14 2015-02-23 Novozymes Inc Methods for preparation of secreted polypeptides having biological activity
US9862956B2 (en) 2006-12-10 2018-01-09 Danisco Us Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
US8680252B2 (en) 2006-12-10 2014-03-25 Dyadic International (Usa), Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
WO2009033071A2 (en) * 2007-09-07 2009-03-12 Dyadic International, Inc. Novel fungal enzymes
WO2018226900A2 (en) 2017-06-06 2018-12-13 Zymergen Inc. A htp genomic engineering platform for improving fungal strains
KR20210018219A (ko) 2018-06-06 2021-02-17 지머젠 인코포레이티드 발효 및 생산 중 곰팡이 형태를 제어하기 위한 신호 전달에 포함된 유전자의 조작
US11479779B2 (en) 2020-07-31 2022-10-25 Zymergen Inc. Systems and methods for high-throughput automated strain generation for non-sporulating fungi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341226C (en) * 1988-08-16 2001-05-01 Wim Van Hartingsveldt Gene replacement as a tool for the construction of aspergillus strains
US5171672A (en) * 1989-08-31 1992-12-15 Allelix Biopharmaceuticals Inc. Recombinant DNA system for Aspergillus
EP0421919A3 (en) * 1989-09-02 1992-04-15 Ciba-Geigy Ag Polygalacturonase encoding fungal expression system
JP2995770B2 (ja) * 1989-12-15 1999-12-27 吉富製薬株式会社 異種蛋白質の製造方法
FI103206B (fi) * 1990-01-29 1999-05-14 Novartis Ag Uusi ilmentämisjärjestelmä sieniä varten
NL9001388A (nl) * 1990-06-19 1992-01-16 Unilever Nv Recombinant dna, cel die daarvan afgeleid dna bevat, enzym waarvoor het recombinant dna codeert en toepassingen daarvan.
PT98419B (pt) * 1990-07-24 1999-01-29 Gist Brocades Nv Processo para a preparacao de sequencias de adn que codificam para xilanases, de construcoes de adn que contem essas sequencias, paraa transformacao de hospedeiros microbianos com essas construcoes, para a preparacao de xilanases por expressao nesses hospedeiros e para a degradacao de xilano por accao dessas xilanases

Also Published As

Publication number Publication date
DE69231995T2 (de) 2002-04-04
CA2123416A1 (en) 1993-06-24
US5705358A (en) 1998-01-06
EP0672149A1 (en) 1995-09-20
ATE204022T1 (de) 2001-08-15
AU3158393A (en) 1993-07-19
ZA929539B (en) 1994-06-09
EP0672149B1 (en) 2001-08-08
JP2866739B2 (ja) 1999-03-08
FI111958B (fi) 2003-10-15
DE69231995D1 (de) 2001-09-13
ES2159519T3 (es) 2001-10-16
DK0672149T3 (da) 2001-11-05
WO1993012237A1 (en) 1993-06-24
FI942691A0 (fi) 1994-06-08
AU664223B2 (en) 1995-11-09
CA2123416C (en) 2003-05-20
JPH07501453A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
FI942691A (fi) Menetelmä tuottaa/erittää proteiinia transformoidun homeen avulla käyttämällä Aspergilluksen endoksylanaasi II-geenistä saatuja ekspressioita/erittämistä sääteleviä alueita
Nicholas et al. The tammar wallaby: a model to study putative autocrine-induced changes in milk composition
ES8205265A1 (es) Un metodo para producir la hormona de crecimiento humano
ATE43635T1 (de) Verfahren zur herstellung von interferon und expressionsvektoren dafuer.
DE69426527D1 (de) Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen
PL240926A1 (en) Process for preparing animal's interferons
ATE154494T1 (de) Verfahren zur herstellung von käse
DE69033006D1 (de) Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt
HK1002915A1 (en) Plant gum material and use thereof in food products
FI942442A (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
Nilsen-Hamilton et al. Secreted proteins, intercellular communication, and the mitogenic response
ATE118982T1 (de) Verfahren zur herstellung von transparenten milchmolkeproteinen und milchmolkeproteinprodukte.
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
ATE153330T1 (de) Neues verfahren zur herstellung von clonidin- derivaten
ATE364088T1 (de) Verfahren zur herstellung von pharmazeutisch aktiver, rekombinanter urokinase umfassend die verwendung von buttersäure oder deren salze
Inagaki et al. Transforming Growth Factorβ Selectively Increases Gene Expression of the Serine/Threonine Kinase Receptor 1 (SKR1) in Human Hepatoma Cell Lines
ES8200882A1 (es) Procedimiento para la preparacion de clorhidrato de acido (2-aminotiazol-4-il)-acetico
ATE265526T1 (de) Genetisch veränderte fibroblasten und ihre verwendung
ATE103978T1 (de) Verfahren zur herstellung eines rinderwachstumshormons mittels eines kunstgens.
DE3853590D1 (de) Rinder granulocyt-makrophagenkolonie stimulierender faktor.
DE3167246D1 (en) Process for producing stabilized hydrolysates of animal proteins, products obtained and dietetic and therapeutic application

Legal Events

Date Code Title Description
MA Patent expired